TOBYSIGN Eye/Ear Drops is a specialized antimicrobial formulation developed for the effective treatment of bacterial infections in the eyes and ears. The key active ingredient, Tobramycin, is a broad-spectrum aminoglycoside antibiotic known for its rapid bactericidal activity and high efficacy against both gram-negative and select gram-positive bacteria. TOBYSIGN is widely used in the management of external infections such as bacterial conjunctivitis, keratitis, blepharitis, and otitis externa, particularly in cases where rapid control of the infection is critical to prevent complications.
Tobramycin works by binding to the bacterial 30S ribosomal subunit, inhibiting protein synthesis, and causing cell death. It is highly effective against common pathogens such as Pseudomonas aeruginosa, Staphylococcus aureus, Haemophilus influenzae, and Escherichia coli. Its pharmacological profile makes it suitable for both ocular and otic applications, offering flexibility and ease of use across different clinical settings.
TOBYSIGN is formulated as a 0.3% Tobramycin solution in a sterile aqueous base, ensuring precision dosing and maximum safety during administration. It is typically instilled as 1–2 drops into the affected eye or ear every 4 to 6 hours, with frequency adjusted based on clinical response. The formulation is free from harmful preservatives and irritants, making it well-tolerated even with prolonged usage.
For ocular infections, TOBYSIGN provides fast relief from symptoms such as redness, discharge, and foreign body sensation, while eradicating the underlying bacterial cause. In otic conditions like swimmer’s ear or bacterial ear canal inflammation, it soothes irritation, reduces bacterial load, and supports a full recovery without the need for systemic antibiotics. It is also frequently used as a prophylactic treatment post minor ophthalmic or otologic procedures.
Manufactured under strict WHO-GMP, ISO, and Schedule M compliance by BluepillExpress, TOBYSIGN Eye/Ear Drops adheres to international quality and sterility standards. Each batch undergoes rigorous testing including sterility, pH, microbial limits, and active pharmaceutical ingredient (API) assay to guarantee consistency and safety. The product is packed in tamper-proof LDPE dropper bottles with easy-to-use nozzles, available in 5 mL and 10 mL variants. Custom fill sizes and packaging options are available to meet specific market and client demands.
TOBYSIGN is supported with comprehensive documentation including Certificate of Analysis, Stability Reports, Method of Analysis, and Regulatory Dossiers in both CTD and ACTD formats for smooth registration and market approval across various regions. The formulation is export-ready and suitable for distribution in semi-regulated and regulated markets including Africa, Latin America, Southeast Asia, and the Middle East.
As a part of BluepillExpress's third-party manufacturing portfolio, TOBYSIGN Eye/Ear Drops can be produced under client-specific brand names with complete support in branding, regulatory filings, packaging design, and logistics. The product is offered with attractive MOQs, flexible production timelines, and complete back-end technical support for smooth integration into the client’s product range.
In conclusion, TOBYSIGN Eye/Ear Drops deliver a robust, reliable, and high-quality therapeutic option for external eye and ear bacterial infections. Its powerful antimicrobial action, backed by global manufacturing standards and comprehensive export documentation, makes it a valuable addition to any pharmaceutical brand’s ophthalmic and ENT product segment. With growing demand for effective localized antibiotic treatments, TOBYSIGN stands as a dependable solution for partners seeking premium third-party manufactured formulations from BluepillExpress.
Description provided by bluepill express.
FIEO Registered
Export Ready
